Our Team

Management Team

President and Founder
Norm Furbush

Joining the US Navy in 1982, Norm “Fuzzy” Furbush spent six years on active duty as a Hospital Corpsman. He began his medical career working on the wards and then in the ICU/CCU, then served with the US Marines and finally finishing up at Cardio-Pulmonary school located in Bethesda, MD. Norm was honorably discharged in 1988.

Norm took his hands on experience to the cardiac catheterization lab at Children’s Hospital DC. He spent 12 years as the Chief Technologist working with the kids, during his tenure he was part of the physician fellowship training program for interventional cardiologists and technologists. He has been part of multiple mission trips to other countries offering his expertise.

For over ten years, Norm held various roles in the medical device industry and collaborated with marketing, product development and provided case coverage for the research team on three different studies.

Over Norm’s 30 year career, he has been developing products in his sketchbook as he watched interventionalists and surgeons struggle with the handling and preparation of multiple medical devices.

Executive Board Member
John Register

Mr. Register’s business career began with Litton Industries in the 1970’s where he gained extensive knowledge and experience in finance, contracts and pricing, program management, mergers and acquisitions, engineering and manufacturing. Mr. Register took that experience and an entrepreneurial drive to a small defense contractor (Technology Applications, Inc. or TAI) in 1985 that was generating approximately $6 million in revenues and lead that firm to over $65 million in revenue prior to the sale of the firm in 1993.

After a short hiatus, Mr. Register joined another small defense firm (Advanced Concepts, Inc. or ACI) in 1995 which consisted of 2 people and $250 thousand in revenue and lead the growth to $45 million before again selling the business in 2007.

Mr. Register is a graduate of the University of Maryland.

Executive Board Member
John Laird, MD

Dr. Laird is the Medical Director of the Adventist Heart and Vascular Institute, St. Helena, CA. He was previously the Medical Director of the Vascular Center and Professor of Medicine at UC Davis Medical Center. He specializes in Cardiovascular Medicine, Interventional Cardiology, Endovascular Therapies, and Vascular Medicine.

He is an Internationally renowned interventional cardiologist who has lectured and performed endovascular procedures around the world. His practice focuses on interventions for carotid artery disease, abdominal and thoracic aorta aneurysmal disease, renal artery disease, peripheral artery disease, and limb salvage techniques.

Among his many areas of leadership and innovation are the investigation of new stents for carotid and peripheral vascular applications, drug coated balloons and drug eluting stents for peripheral artery disease and the development of laser angioplasty.

Dr. Laird is known for innovation, teaching vascular interventions to other physicians, and his role in organizing and conducting clinical trials of new therapies for vascular disease.

Global Director of Sales
Larry Kronick

Mr. Lawrence Kronick (Larry) has over thirty-five years of operational experience in international sales, specifically in the areas of high tech sales, marketing, and business development. He specializes in assisting medical device and equipment companies to define and implement successful business strategies and ventures in international markets.

Prior to establishing BAC, Inc. (BAC) Larry was based in Hong Kong as the Asia Distributor Manager for Acuson, a leading manufacturer of diagnostic ultrasound equipment.  In his six years at Acuson, he was responsible for the development and management of Acuson’s business in Asia-Pacific, excluding Japan.  During his tenure at Acuson he achieved significant market share gains and his region became the fastest growing and most profitable region in the world for Acuson.

Prior to Acuson, Larry spent five years living and working in Beijing for a large medical and scientific instrument trading company (U.S. China Industrial Exchange, Inc.).  While based in China, he was responsible for new product development, oncology products, and diagnostic imaging equipment sales.

Since establishing BAC in 1994, Larry has worked with a variety of medical equipment, disposable and software manufacturers to establish their presence in the United States and international markets.

Larry is fluent in Mandarin and has a basic knowledge of several other Chinese Dialects.

Medical Advisory Board

George Adams, MD

Dr. George Adams is an Interventional Cardiologist at Rex Hospital affiliated with the University of North Carolina at Chapel Hill.  He completed his Internal Medicine Internship and Residency at the University of Texas Southwestern and his General Cardiology, Interventional Cardiology and Masters of Health Sciences at Duke University.  He is currently a Clinical Associate Professor of Medicine at the University of North Carolina at Chapel Hill and is the Director of Cardiovascular and Peripheral Vascular Research at Rex Hospital.

Dr. Adams is well published in the field of complex peripheral vascular interventions in critical limb ischemic patients, development of regional systems of care for STEMI, and nuclear cardiology techniques.  He currently leads a robust clinical research program enrolling patients in approximately 20 peripheral, carotid and coronary trials and is involved with device development for the management of coronary and peripheral vascular disease.

Robert M. Bersin, MD

Robert M. Bersin, MD, MPH is Emeritus Medical Director of Structural Heart and Endovascular Services, Swedish Medical Center, Seattle, Washington. He received a Bachelor of Arts Degree in Psychology and a Bachelor of Science Degree in Biology from Stanford University in 1976. He then attended the University of California, Los Angeles, Schools of Medicine and Public Health and received a Doctor of Medicine and a Master of Public Health in Health Services Administration in 1981.

Dr. Bersin has a long history of basic and clinical research involvement. He was as a doctoral researcher at the World Health Organization in Lausanne, Switzerland and was a recipient of the Physician-Scientist Award of the National Institutes of Health, and of the National Center Research Award of the American Heart Association. He has authored more than seventy abstracts, book chapters, and original articles, and has directed or participated in more than eighty clinical trials.

Robert Gallino, MD

Dr. Rob Gallino is the Director of Peripheral Vascular Interventions at Medstar Montgomery Medical Center in Olney, MD and a Cardiologist specializing in coronary and peripheral interventions..

He practices in the Washington Metropolitan area and has received numerous awards for his work in cardiology, including the Washingtonian Magazines “Top Doctor” award. Dr. Gallino has participated in multiple studies and written, researched and served as a faculty member at multiple US and International conferences on these topics.

Marsha Holton, CCRN

Marsha has been a registered nurse since 1979. During her nursing career she has met many who individuals who have been willing to help her learn how to take care of patients in the cardiac cath lab (CCL). Marsha’s commitment has led to active participation on the Board of Directors for the Society of Cardiovascular Professionals, and she helped compile the Orientation Guidelines for Cardiac Catheterization Laboratory (CCL) field, which significantly impacts the development of cardiac cath lab professionals throughout the United States.

Marsha has also served as the Resource Nurse for the American Association of Critical Nurses for Cardiac Catheterization in the Greater Washington Area Conference (GWAC) Resource for the Cath Lab nurses with the AACN.

She has been invited as a faculty member to a number meetings and key scientific sessions in the cardiovascular field. Marsha feels her life has been truly blessed, with good friends, smart people, all looking to the achieve the same goals and that is to give patients the best care possible.

Julie Logan, RN, BS

Ms. Logan is a world leader in cardiovascular education.  She brings extensive clinical, research and business expertise to the cardiovascular field.  Julie previously served as the Chief Operating Officer for the Foundation for Cardiovascular Medicine an organization dedicated to education and clinical research in cardiovascular disease. She has over 20 years of experience in the medical field, performing complex coronary, vascular and structural interventions.

Julie has served on the scientific advisory boards of several large Cardiovascular Corporations and consulted in a variety of Cardiovascular projects including, New Stent Designs, Percutaneous Valve Therapy, Peripheral Vascular Disease, Vascular Closure and Brachytherapy, to name a few.

Julie holds several medical patents and continues to work with many thought leaders around the world developing new technology to advance the field of Cardiovascular Medicine.

James Patrick Zidar, MD

Dr. Zidar is a clinical professor of medicine at the University of North Carolina at Chapel Hill. Additionally he is Corporate Chief, Department of Cardiology, Rex Healthcare and he serves as Consultant in Cardiology, Rex Hospital, and Consultant in Cardiology, Duke Raleigh Hospital. He is board certified by National Board of Medical Examiners, American Board of Internal Medicine ABIM, Cardiovascular Disease and ABIM, Interventional Cardiology.

His current research interests include: complex coronary interventions, renal artery stenosis, innovative endovascular technologies to treat cardiovascular disease, carotid revascularization, peripheral arterial disease, management of refractory hypertension, and evaluation of critical limb ischemia. He has authored over 60 manuscripts, 15 book chapters, 100 abstracts and was the SCAI representative for the writing committee of the 2011 and 2012 NonSTEMI/Unstable angina guidelines.

Nick Cavros, MD

Dr. Nick Cavros is a Cardiologist at the Cardiovascular Institute of the South, practicing at Lafayette General Hospital. Dr. Cavros is board certified in cardiovascular disease and interventional cardiology. He is fellow of the American College of Cardiology.

Dr. Cavros specializes in performing coronary and peripheral interventional procedures to treat coronary and peripheral arterial disease. Dr. Cavros has participated in multiple studies and written, researched and served as a faculty member at multiple US and International conferences on these topics.

Kelly W. Elliott, RN, MS

Kelly has more than 20 years of experience in the medical device industry and more than 12 years of experience in global medical device clinical research. She has a strong clinical background from her positions as a Medical-Surgical ICU RN, Open Heart Surgery ICU RN, and Cardiac Cath Lab RN early in her career. Previously, Kelly has held multiple Vice President of Clinical Affairs positions for medical device companies where she strategized, designed, and executed global clinical trials including international multi-center FDA-regulated IDE / NSR studies for new device approvals, double-blind randomized controlled device trials, and post-market studies.

Kelly holds a B.S.N. degree from San Jose State University, and M.S. from UC San Francisco. Kelly is now President and CEO of a premier consulting organization providing expertise in clinical, regulatory, and quality consulting.  The clinical and data management operations focus on expert design and conduct of research with a personal approach to meet medical device companies’ corporate goals and promote successful execution of all medical device trials from FIH to feasibility to pivotal trials to post market studies

Lawrence Garcia, MD

Dr. Garcia received his training in Cardiology at the University of Iowa Hospitals and Clinics in Iowa City, Iowa and as an interventional cardiologist at the Beth Israel Deaconess Medical Center, Harvard Medical School. Further, he received his peripheral vascular training at St. Elizabeth’s Medical Center, Tufts University, Boston, Massachusetts.

Dr. Garcia then served at the Beth Israel Hospital as a full time interventional cardiologist and Director of the Peripheral Cardiovascular Program and Peripheral Interventions at the Beth Israel Deaconess Medical Center as well as the Director of the Interventional Fellowship Program and has now returned to St. Elizabeth’s Medical Center as Chief of the Section of Interventional Cardiology and Vascular Medicine Programs.

Dr. Garcia continues his research interests in a wide variety of studies including peripheral vascular interventional trials and has served as national or global principal investigator on several trials. He is widely regarded as an expert in peripheral vascular disease and specifically in atherectomy for lower extremity revascularization. His work has been presented in numerous manuscripts, abstracts, textbooks and textbook chapters.

John Laird, MD

Dr. Laird is the Medical Director of the Adventist Heart and Vascular Institute, St. Helena, CA. He was previously the Medical Director of the Vascular Center and Professor of Medicine at UC Davis Medical Center. He specializes in Cardiovascular Medicine, Interventional Cardiology, Endovascular Therapies, and Vascular Medicine.

He is an Internationally renowned interventional cardiologist who has lectured and performed endovascular procedures around the world. His practice focuses on interventions for carotid artery disease, abdominal and thoracic aorta aneurysmal disease, renal artery disease, peripheral artery disease, and limb salvage techniques.

Among his many areas of leadership and innovation are the investigation of new stents for carotid and peripheral vascular applications, drug coated balloons and drug eluting stents for peripheral artery disease and the development of laser angioplasty.

 Dr. Laird is known for innovation, teaching vascular interventions to other physicians, and his role in organizing and conducting clinical trials of new therapies for vascular disease.

Jihad A. Mustapha, MD

Dr. Mustapha is a board-certified interventional cardiologist.  He specializes in minimally invasive, non-surgical therapy for heart and peripheral vascular disease (PAD), specifically critical leg ischemia (CLI).  He has advanced training in coronary stent and complex peripheral vascular disease treatments including laser, atherectomy, and totally occluded arteries.

Dr. Mustapha graduated from Wayne State University and St. George University School of Medicine.  He has completed Fellowships in both Cardiology and Interventional Cardiology at Louisiana State University School of Medicine.

He is currently in practice at Advanced Cardiac & Vascular Centers for Amputation Prevention, Grand Rapids, MI, where he is President and Chief Executive Officer, Director of Endovascular Interventions.

Dr. Mustapha serves as Clinical Associate Professor of Medicine at Michigan State University College of Osteopathic Medicine, and is the Founder and Director of the AMPutation Prevention Symposium (AMP) and Founding Board Member of the CLI Global Society.   He has authored multiple publications, including those on critical limb ischemia and amputation prevention.

Robert Martin, DO

Dr. Robert Martin is an orthopedic surgeon treating a wide range of orthopedic problems with a special interest in advanced arthroscopic surgery, sports medicine, knee and should problems.

He is associated with Carolina Regional Orthopedics and  board certified by The American Board of Orthopedic Surgery and the National Board of Osteopathic Medical Examiners. Dr Martin is a retired US Navy Captain.

Purchasing

888.505.8802 main
888.853.6559 fax
info@syntervention.com

Bringing Synergy to Intervention.

888.505.8802

info@syntervention.com